Analysts Issue Forecasts for Tourmaline Bio FY2025 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Chardan Capital boosted their FY2025 earnings per share (EPS) estimates for Tourmaline Bio in a research note issued on Monday, May 5th. Chardan Capital analyst D. Gataulin now anticipates that the company will earn ($3.93) per share for the year, up from their prior forecast of ($4.10). […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Chardan Capital boosted their FY2025 earnings per share (EPS) estimates for Tourmaline Bio in a research note issued on Monday, May 5th. Chardan Capital analyst D. Gataulin now anticipates that the company will earn ($3.93) per share for the year, up from their prior forecast of ($4.10). […]
